From SARS-CoV-2 to analgesia: harnessing the vascular endothelial growth factor A/neuropilin 1 axis for pain therapy

Pain. 2023 Jul 1;164(7):1403-1405. doi: 10.1097/j.pain.0000000000002851. Epub 2022 Dec 15.
No abstract available

MeSH terms

  • Analgesia*
  • COVID-19*
  • Humans
  • Neuropilin-1 / metabolism
  • Pain / drug therapy
  • Receptors, Vascular Endothelial Growth Factor / metabolism
  • SARS-CoV-2 / metabolism
  • Vascular Endothelial Growth Factor A / metabolism

Substances

  • Vascular Endothelial Growth Factor A
  • Neuropilin-1
  • Receptors, Vascular Endothelial Growth Factor